Diligence memo · auto-generated · as of July 2, 2026

Alloy Health, Inc.

Alloy Health, Inc. looks over-valued against its niche peers and is quiet on financing cadence.

SourceRaising on rhythm with a 6.0× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Alloy Health, Inc. operates in Healthtech, based in NEW YORK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Alloy Health, Inc. has raised $17M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $15M on 2024-10-17.

Most recent recorded round closed around 2024-10-17.

Valuation (modeled)modeled

Provath models Alloy Health, Inc. at approximately $67M (range $19M–$135M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.60× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 48 months.

Last raise 20 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round stepped up 6.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 78% of Healthtech peers (2138 compared).

Modeled value ranks above 68% of those peers.

Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.